The other commonly used drugs, such as leukotriene antagonists, long‐ and short‐acting β‐receptor agonists, and immunoglobulin E (IgE) monoclonal antibodies, have failed to achieve satisfactory results during asthma (Girodet et al., 2011). Here, IGHE is linked to asthma.